http://archive2.mrc.org/taxonomy/term/8695/all en http://archive2.mrc.org/articles/ny-times-slants-patent-protection-story-against-novartis <div class="field field-type-nodereference field-field-source"> <div class="field-items"> <div class="field-item odd"> <div class="field-label-inline-first"> By</div> <a href="/author/ken-shepherd">Ken Shepherd</a> </div> </div> </div> <p >    New York Times reporter Amelia Gentleman subtly slanted her <a href="http://www.nytimes.com/2007/01/30/business/worldbusiness/30novartis.html?_r=1&oref=slogin" />January 30 story</a> on a pending Indian court case regarding drugs patents by directing readers to see prescription drugs as a “right.” </p> <br /> <p >     “The supply of low-cost generic versions of cancer and AIDS treatments for the developing world could be blocked if Novartis wins a legal challenge to India’s patent law, patients’ rights groups have contended,” wrote Gentleman in her first paragraph. </p><p><a href="http://archive2.mrc.org/articles/ny-times-slants-patent-protection-story-against-novartis" target="_blank">read more</a></p> Articles MRC Business Health DoctorsWithoutBorders MediaBias NewYorkTimes Novartis Oxfam patent Tue, 30 Jan 2007 22:08:50 +0000 admin 25641 at http://archive2.mrc.org